Maintelyte

Magnesium Chloride Hexahydrate, the active ingredient in Maintelyte, is an electrolyte solution presented as a solution for injection for intravenous use. It replaces fluids and corrects electrolyte imbalances in patients with dehydration or hypovolemia.

GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Maintelyte is an intravenous electrolyte solution used in conditions that involve fluid loss or electrolyte disturbance. - Dehydration: restores intravascular volume and normalizes electrolyte concentrations. - Hypovolemia: replenishes circulating blood volume to maintain tissue perfusion. - Electrolyte imbalance: provides essential ions such as magnesium, potassium, and sodium to correct deficits. - Fluid replacement: supplies isotonic fluid to support hemodynamic stability.

Maintelyte may be associated with infusion‑related reactions and electrolyte‑related disturbances.

Common Side Effects: - Mild pain or irritation at the injection site. - Transient flushing or warmth during infusion. - Slight increase in serum potassium levels. - Mild nausea or vomiting. - Temporary elevation of blood glucose.

Serious or Rare Side Effects: - Hypermagnesemia leading to muscle weakness or cardiac arrhythmia. - Severe hyperkalemia causing cardiac conduction abnormalities. - Anaphylactic or severe allergic reaction. - Metabolic acidosis from acetate metabolism. - Fluid overload resulting in pulmonary edema.

Maintelyte should be administered with careful monitoring of fluid status and electrolyte levels. - Assess patient hydration and electrolyte baseline before infusion. - Monitor cardiac rhythm and serum electrolytes during therapy. - Adjust infusion rate in patients with renal impairment. - Avoid rapid infusion in patients at risk of fluid overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Maintelyte may interact with medications that affect electrolyte balance or fluid status.

Major Interactions (Avoid): - Concurrent use of potassium‑sparing diuretics may cause dangerous hyperkalemia. - Intravenous calcium channel blockers combined with high magnesium may exacerbate hypotension.

Moderate Interactions (Monitor Closely): - Loop diuretics can increase loss of administered electrolytes, requiring dose adjustment. - Insulin therapy may enhance cellular uptake of potassium, affecting serum levels. - ACE inhibitors may potentiate hyperkalemia when combined with potassium‑rich solutions.